Milbenin 2,5 mg/25 mg is an antiparasitic for small dogs and puppies, suitable for the treatment of mixed infections with adult cestodes and nematodes sensitive to praziquantel and milbemycin oxime. It can also be used for prevention of heartworm disease if concurrent treatment against cestodes is required. Milbenin 2,5 mg/25 mg is among the veterinary drugs available without veterinary prescription (VRIJ).
Milbenin 2,5 mg/25 mg has the registration number NL 129069.
Treatment of mixed infections with adult cestodes and nematodes of the following species sensitive to praziquantel and milbemycin oxime:
The veterinary drug may also be used for prevention of heartworm disease (Dirofilaria immitis) if concomitant treatment against cestodes is required.
For oral use.
Recommended minimum dose: 0,5 mg milbemycin oxime and 5 mg praziquantel per kg body weight are administered once.
Administer the veterinary drug with or after some food.
Depending on the dog's body weight, the practical dosage is as follows:
Weight 1-5 kg = 1 chewable tablet Milbenin 2,5 mg/25 mg chewable tablets for small dogs and puppies.
To ensure correct dosing, body weight should be determined as accurately as possible to avoid underdosing.
When the veterinary medicinal product is used for the prevention of heartworm disease and simultaneously requires treatment against tapeworms, the veterinary medicinal product may replace the monovalent veterinary medicinal product for the prevention of heartworm disease.
For the treatment of Angiostrongylus vasorum infections, milbemycin oxime should be administered four times at one-week intervals. It is recommended that, if concomitant treatment against cestodes is indicated, treatment with the veterinary medicinal product should be continued with the monovalent veterinary medicinal product containing only milbemycin oxime for the remaining three weekly treatments.
Administration of the veterinary medicine every four weeks in endemic areas prevents angiostrongyosis by reducing immature adult (L5) and adult parasites, where concomitant treatment against cestodes is indicated.
For treatment against Thelazia callipaeda, milbemycin oxime should be administered as 2 treatments seven days apart. If concomitant treatment against cestodes is indicated, the veterinary medicinal product may replace the monovalent veterinary medicinal product containing milbemycin oxime alone.
Per chewable tablet:
Active ingredients:
Milbemycin oxime 2,5 mg
Praziquantel 25,0 mg
White to off-white, round chewable tablets with evenly distributed brown pigmentation.
Very rarely (<1 animal / 10,000 animals treated, including isolated reports):
